EDP Sciences logo
Submit your paper
Search
Menu
All issues Volume 40 / No 2 (June 2008) J Extra Corpor Technol, 40 2 (2008) 94-98 References
Free Access
Issue
J Extra Corpor Technol
Volume 40, Number 2, June 2008
Page(s) 94 - 98
DOI https://doi.org/10.1051/ject/200840094
Published online 15 June 2008
  1. Mann KG. Thrombin formation. Chest. 2003;124(3 Suppl):4S–10S. [CrossRef] [PubMed] [Google Scholar]
  2. Aziz O, Athanasiou T, Darzi A. Haemostasis using a ready-to-use collagen sponge coated with activated thrombin and fibrinogen. Surg Technol Int. 2005;14:35–40. [Google Scholar]
  3. Hashemi K, Donaldson LJ, Freeman JW, Sokhi GS, Gyde OH, Smith HV. The use of topical thrombin to reduce wound haematoma in patients receiving low-dose heparin. Curr Med Res Opin. 1981;7:458–62. [CrossRef] [PubMed] [Google Scholar]
  4. Suzuki R, Matsuhashi M, Kuwahara T, Kase T. Topical use of thrombin in prostatic surgery. Hinyokika Kiyo. 1986;32:1461–64. [PubMed] [Google Scholar]
  5. Ofodile FA, Sadana MK. The role of topical thrombin in skin graft-ing. J Natl Med Assoc. 1991;83:416–8. [Google Scholar]
  6. Sarpel U, Roayaie S, Schwartz ME, Labow DM. The role of fibrin sealants in hepatic surgery. Surg Technol Int. 2007;16:31–6. [Google Scholar]
  7. Franz RC. Platelet concentrate-thrombin coagulum: a new biological dressing for the promotion of wound healing. S Afr Med J. 1987;72:810–1. [PubMed] [Google Scholar]
  8. Amrani DL, Diorio JP, Delmotte Y. Wound healing. Role of comercial fibrin sealants. Ann N Y Acad Sci. 2001;936:566–79. [Google Scholar]
  9. Moore M, Burak WJr, Nelson E, et al. Fibrin sealant reduces the duration and amount of fluid drainage after axillary dissection: a randomized prospective clinical trial. J Am Coll Surg. 2001;19: 591–9. [CrossRef] [PubMed] [Google Scholar]
  10. Slater M, Patava J, Kingham K, Mason RS. Involvement of platelets in stimulating osteogenic activity. J Orthop Res. 1995;13:655–63. [CrossRef] [PubMed] [Google Scholar]
  11. Anitua E, Andia I, Ardanza B, Nurden P, Nurden AT. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost. 2004;91:4–15. [CrossRef] [PubMed] [Google Scholar]
  12. Crow SS, Sullivan VV, Aysola AE, et al. Postoperative coagulopathy in a pediatric patient after exposure to bovine topical thrombin. Ann Thorac Surg. 2007;83:1547–9. [CrossRef] [Google Scholar]
  13. Neschis DG, Heyman MR, Cheanvechai V, Benjamin ME, Flinn WR. Coagulopathy as a result of factor V inhibitor after exposure to bovine topical thrombin. J Vasc Surg. 2002;35:400–2. [CrossRef] [Google Scholar]
  14. Beghi E, Gandolfo C, Ferrarese C, et al. Bovine spongiform encephalopathy and Creutzfeldt-Jacob disease: Fact and uncertainties underlying the causal link between animal and human disease. Neurol Sci. 2004;25:122–9. [CrossRef] [PubMed] [Google Scholar]
  15. Cohn E, Oncley J, Strong L, Hughes WJr, Armstrong HJr. Chemical, clinical, and immunological studies on the products of human plasma fractionation I. The characterization of the protein fractions of human plasma. J Clin Invest. 1944;23:417–32. [CrossRef] [PubMed] [Google Scholar]
  16. Fenton J2nd, Fasco M, Stackrow A. Human thrombins. Production, evaluation, and properties of alpha-thrombin. J Biol Chem. 1977;252:3587–98. [CrossRef] [Google Scholar]
  17. Seegers W. Activation of purified prothrombin. Proc Soc Exp Biol Med. 1949;72:677–80. [CrossRef] [Google Scholar]
  18. Stocker K, Hauer H, Muller C, Triplett DA. Isolation and characterization of Textarin, a prothrombin activator from eastern brown snake (Pseudonaja textilis) venom. Toxicon. 1994;32:1227–36. [CrossRef] [Google Scholar]
  19. Kumar V, Madsen T, Zhu H, Semple E. Stability of human thrombin produced from 11 ml of plasma using the Thrombin Processing Device—TPD™. J Extra Corpor Technol. 2005;37:390–5. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  20. Kumar V, Chapman JR. Whole blood thrombin: development of a process for intra-operative production of human thrombin. J Extra Corpor Technol. 2007;39:18–23. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  21. Semple E, Madsen T, Semple J. Quality of thrombin produced from the patient’s own plasma using the TPD”, a new thrombin processing device. J Extra Corpor Technol. 2005;37:196–200. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  22. Yoshida H, Hirozane K, Kamiya A. Adhesive strength of autologous fibrin glue. Biol Pharm Bull. 2000;23:313–7. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.